Skip to Main Content

Paper Details

BMS, IMS, EMAS, RCOG and AMS joint statement on menopausal hormone therapy and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020.
Post Reprod Health
5
2021
Author NameAffiliation
Haitham HamodaKing's College Hospital
Susan R Davis
Susan R Davis
Antonio Cano
Edward MorrisNorfolk & Norwich University Hospital
Sonia L Davison
Nick PanayQueen Charlotte's and Chelsea & Westminster Hospitals
Mary Ann LumsdenGlasgow Royal Infirmary, University of Glasgow
Tim HillardPoole Hospital NHS Foundation Trust, Poole Hospital
Tommaso Simoncini
  • 1 - 10

Datasets

Release 1.2